Product Images Amlodipine And Valsartan

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Amlodipine And Valsartan NDC 45865-890 by Medsource Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pdp - 890

pdp - 890

This is a product description for the medication Amlodipine & Valsartan available in tablet form with a strength of 5/320mg. The tablets serve as a generic alternative for a medication called Exforge. The text also includes a manufacturer's name, Srurobiido Pharla TD, and a warning not to take the medication if not prescribed by a physician.*

Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - amlo val fig1

Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - amlo val fig1

Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - amlo val fig2

Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - amlo val fig2

This is a graph showing the probability of achieving Diastolic Blood Pressure (DBP) lower than 90 mmHg at Week 8 with Amiodipine and Valsartan Tablets at 10 mg/320 mg. The graph includes baseline DBP values ranging from 100 to 110 mmHg. There is also a mention of Valsartan 320 mg, Amiodipine 10 mg, and placebo.*

Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - amlo val fig3

Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - amlo val fig3

This document appears to be a medical report showing a chart with the probability of achieving a systolic blood pressure of less than 130 mmHg after taking Amlodipine and Valsartan tablets that contain 10mg Amiodipine and 320mg Valsartan. The chart is based on a baseline systolic blood pressure measurement taken at Week 8. There is also a placebo listed in the ingredients but no additional information is available.*

Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - amlo val fig4

Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - amlo val fig4

The text describes a graph showing the probability of achieving a diastolic blood pressure of less than 80 mmHg at week 8 for a combination of Amlodipine and Valsartan tablets with 10mg and 320mg doses respectively, compared to a placebo. The graph shows baseline DBP values of 100, 105, and 110 and has no other discernible information.*

Chemical Structure1 - amlo val str1

Chemical Structure1 - amlo val str1

Chemical Structure2 - amlo val str2

Chemical Structure2 - amlo val str2

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.